Guides
Pulmonary fibrosis on a CT report: does it mean IPF?
Pulmonary fibrosis and idiopathic pulmonary fibrosis are not interchangeable. Understand the next assessment and prepare an ILD specialist review in China.
By MedicCN, Editorial research · published 2026-10-21 · sources checked 2026-10-21
English article prepared on 21 October 2026 using the linked medical-society, public-health and hospital sources. Source verification is not clinical review: this article has not undergone independent clinical review. Hospital descriptions do not establish a partnership, overseas-patient eligibility or a confirmed appointment.
Does “fibrosis” on the report mean IPF?
No. Pulmonary fibrosis means scarring in the lungs. Idiopathic pulmonary fibrosis, or IPF, is one particular diagnosis. A doctor needs to assess the scan alongside your history and consider other causes before making that diagnosis.
‘Idiopathic’ means that no cause has been identified. A report describing scarring is therefore not making the same claim as a clinician diagnosing IPF. Keep the exact wording: a localised scar, fibrotic changes and a suggested interstitial pattern should not all be translated into the same disease name.
The immediate task is to establish what the radiologist saw, how extensive it is and how it fits your history. Ask the referring clinician whether the report describes an incidental finding or a suspected interstitial lung disease that needs specialist evaluation. Do not use the phrase alone to select treatment or to apply an online prognosis to yourself.
What your specialist needs to know
An interstitial lung disease assessment looks beyond the lungs’ appearance. Medical conditions, medicines, occupational or household exposures and family history may help explain the findings.
Prepare a dated account of breathing symptoms and relevant diagnoses, together with medicines and previous treatments. Include the work and home exposures you know about, even if you are unsure whether they matter. A history of autoimmune disease or similar lung disease in relatives is worth bringing to the consultation.
The point is not to identify the cause yourself. A written timeline helps the specialist ask more precise questions and decide which existing findings need further investigation. Do not stop a prescribed medicine because its name appears on a list of possible causes; discuss the concern with the prescribing clinician.
What do CT, lung function and blood tests each add?
These tests answer different questions. CT examines the pattern of lung changes; lung-function testing assesses how the lungs work; selected blood tests may help investigate an underlying condition.
High-resolution CT can help characterise the pattern, while lung-function results provide information that a scan alone cannot supply. An ILD team may also consider blood tests for autoimmune disease. Additional procedures, including lavage or a biopsy, are selected according to the unresolved question and the patient’s circumstances, not ordered automatically for everyone with the word ‘fibrosis’ in a report.
Bring existing results before arranging new tests. If an invasive investigation is proposed, ask what competing diagnoses it could distinguish, how the result would change management and what the risks are for you. A second review should explain the need for another investigation, rather than simply repeat the first work-up.
| Record | What it contributes |
|---|---|
| CT studies and reports | The pattern, distribution and changes across dates |
| Lung-function results | A baseline and any measured change in function |
| Relevant blood tests and clinical letters | Evidence about possible associated conditions |
| Previous pathology, if performed | An additional source of diagnostic evidence |
Why might an ILD team review the case together?
A multidisciplinary review combines the clinical history with specialist imaging interpretation and, where relevant, pathology. It can help establish how confident the team is in a diagnosis and what remains unresolved.
NICE’s IPF guidance specifies multidisciplinary consensus for diagnosis, drawing on clinical features, lung function, imaging and pathology when indicated. The team’s composition depends on the stage of assessment. This UK guidance explains the diagnostic principle; it does not certify an individual Chinese hospital or make every listed test necessary for every patient.
Ask for the working diagnosis, the evidence supporting it and the remaining alternatives. If the team remains uncertain, request a plan for resolving or monitoring that uncertainty. If the diagnosis remains uncertain, ask which possibilities are still being considered and whether further testing would change treatment.
Seeing an ILD specialist in China
Look for a service that explicitly describes interstitial lung disease, then confirm the case-review and registration route. A general respiratory appointment and a formal ILD discussion are not necessarily the same booking.
China–Japan Friendship Hospital’s Respiratory Medicine Division Three describes an ILD service with dedicated outpatient and inpatient work. It provides a specific institutional starting point for an enquiry about suspected fibrosis. Its department profile does not establish remote access, English-language consultation or acceptance of your case; those details need confirmation through the hospital.
Send a concise initial enquiry with the existing diagnosis or report wording, your question and an inventory of available records. Confirm the secure transfer route before sending the scans. Ask your current clinician whether travel is appropriate, especially if you use oxygen or your breathing has recently worsened. New severe breathlessness needs local assessment, not a wait for an international appointment. Any longer-term plan must also identify who will supervise care after you return home.